{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:26:35Z","timestamp":1765232795514,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"MyMD Pharmaceuticals and the Starwood Trust Foundation."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jneuroim.2019.577115","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T11:32:19Z","timestamp":1574249539000},"page":"577115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["MYMD-1, a novel alkaloid compound, ameliorates the course of experimental autoimmune encephalomyelitis"],"prefix":"10.1016","volume":"339","author":[{"given":"Justin D.","family":"Glenn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzy Morales","family":"Pantoja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizio","family":"Caturegli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine A.","family":"Whartenby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.jneuroim.2019.577115_bb0005","doi-asserted-by":"crossref","first-page":"v3","DOI":"10.1007\/s00415-005-5002-7","article-title":"The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage","volume":"252","author":"Bruck","year":"2005","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2019.577115_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.wco.0000169736.60922.20","article-title":"The spectrum of multiple sclerosis: new lessons from pathology","volume":"18","author":"Bruck","year":"2005","journal-title":"Curr. Opin. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2019.577115_bb0015","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1210\/en.2012-1452","article-title":"Anatabine ameliorates experimental autoimmune thyroiditis","volume":"153","author":"Caturegli","year":"2012","journal-title":"Endocrinology."},{"issue":"9648","key":"10.1016\/j.jneuroim.2019.577115_bb0020","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.jneuroim.2019.577115_bb0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijantimicag.2014.06.001","article-title":"Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities","volume":"44","author":"Cushnie","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.jneuroim.2019.577115_bb0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaut.2008.04.017","article-title":"Role of Th1 and Th17 cells in organ-specific autoimmunity","volume":"31","author":"Dardalhon","year":"2008","journal-title":"J Autoimmun."},{"issue":"5","key":"10.1016\/j.jneuroim.2019.577115_bb0035","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4049\/jimmunol.1801238","article-title":"MYMD-1, a novel Immunometabolic regulator, ameliorates autoimmune thyroiditis via suppression of Th1 responses and TNF-alpha release","volume":"202","author":"Di Dalmazi","year":"2019","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2019.577115_bb0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.20160517","article-title":"CNS-targeted autoimmunity leads to increased influenza mortality in mice","volume":"214","author":"Glenn","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2019.577115_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2017.12.002","article-title":"Gemcitabine directly inhibits effector CD4 T cell activation and prevents experimental autoimmune encephalomyelitis","volume":"316","author":"Glenn","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2019.577115_bb0050","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"P T."},{"issue":"3","key":"10.1016\/j.jneuroim.2019.577115_bb0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.7224\/1537-2073.2012-053","article-title":"Natural history of multiple sclerosis symptoms","volume":"15","author":"Kister","year":"2013","journal-title":"Int. J. MS Care"},{"issue":"6","key":"10.1016\/j.jneuroim.2019.577115_bb0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.smim.2007.10.007","article-title":"Th17 cells: effector T cells with inflammatory properties","volume":"19","author":"Korn","year":"2007","journal-title":"Semin. Immunol."},{"issue":"8","key":"10.1016\/j.jneuroim.2019.577115_bb0065","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1074\/jbc.M115.694687","article-title":"Identifying a small molecule blocking antigen presentation in autoimmune thyroiditis","volume":"291","author":"Li","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.jneuroim.2019.577115_bb0070","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.4049\/jimmunol.0902212","article-title":"Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses","volume":"183","author":"Nizri","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2019.577115_bb0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2249.2009.04040.x","article-title":"Translational mini-review series on Th17 cells: CD4 T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation","volume":"159","author":"O\u2019Connor","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.jneuroim.2019.577115_bb0080","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S1474-4422(06)70581-6","article-title":"Sex ratio of multiple sclerosis in Canada: a longitudinal study","volume":"5","author":"Orton","year":"2006","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2019.577115_bb0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1734-1140(11)70500-X","article-title":"Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions","volume":"63","author":"Rogosnitzky","year":"2011","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.jneuroim.2019.577115_bb0090","doi-asserted-by":"crossref","first-page":"E137","DOI":"10.1210\/jc.2013-2951","article-title":"Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto\u2019s) thyroiditis: a randomized controlled clinical trial","volume":"99","author":"Schmeltz","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.jneuroim.2019.577115_bb0095","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.4049\/jimmunol.0803631","article-title":"Signal transduction inhibition of APCs diminishes th17 and Th1 responses in experimental autoimmune encephalomyelitis","volume":"182","author":"Skarica","year":"2009","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2019.577115_bb0100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jphs.2014.12.016","article-title":"Involvement of stimulation of alpha7 nicotinic acetylcholine receptors in the suppressive effect of tropisetron on dextran sulfate sodium-induced colitis in mice","volume":"127","author":"Tasaka","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jneuroim.2019.577115_bb0105","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1146\/annurev.arplant.59.032607.092730","article-title":"Alkaloid biosynthesis: metabolism and trafficking","volume":"59","author":"Ziegler","year":"2008","journal-title":"Annu. Rev. Plant Biol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572819302206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572819302206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:34:52Z","timestamp":1759048492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572819302206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":21,"alternative-id":["S0165572819302206"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577115","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MYMD-1, a novel alkaloid compound, ameliorates the course of experimental autoimmune encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577115"}}